Labia Minora, Labia Majora, and Clitoral Hood Alteration: Experience-Based Recommendations—A 10-Year Follow-up Report
Aesthetic Surgery Journal · 18.08.2026 · 46 (9) · 937-938
DOI: 10.1093/asj/sjag147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 18.08.2026. Verfasst von John G Hunter. Hauptthemen laut MEDLINE: Vulva, Clitoris, Plastic Surgery Procedures. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
This article reports an experience-based 10-year follow-up of a January 2016 Aesthetic Surgery Journal paper that reviewed over 600 cases of labiaplasty and clitoral hood alteration. Long-term follow-up reports of published articles have been recommended to evaluate the original paper's results and conclusions. This is a summary of the author’s subsequent labiaplasty experience, evaluating his original technical suggestions and caveats for their validity after performing an additional 800 female external genital aesthetic surgical procedures. The more recent experience of the author indicates that the findings and suggestions in his 2016 article remain valid. Level of Evidence: 5 (Therapeutic) For image description, please refer to the figure legend and surrounding text.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Hunter, J. G. (2026). Labia Minora, Labia Majora, and Clitoral Hood Alteration: Experience-Based Recommendations—A 10-Year Follow-up Report. Aesthetic Surgery Journal, 46(9), 937-938. https://doi.org/10.1093/asj/sjag147
Vancouver
Hunter JG. Labia Minora, Labia Majora, and Clitoral Hood Alteration: Experience-Based Recommendations—A 10-Year Follow-up Report. Aesthetic Surgery Journal. 2026;46(9):937-938. doi:10.1093/asj/sjag147
BibTeX
@article{Hunter2026,
author = {Hunter, John G},
title = {Labia Minora, Labia Majora, and Clitoral Hood Alteration: Experience-Based Recommendations—A 10-Year Follow-up Report},
journal = {Aesthetic Surgery Journal},
year = {2026},
volume = {46},
number = {9},
pages = {937--938},
doi = {10.1093/asj/sjag147}
}
EUVIMED